Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
For those studying how synthetic GLP-1 agonists might perform under simulated glucose load or behavioral conditioning models, this formulation presents a structured and reliable entry point
Our unflavoured powder mixes easily with water or juice, making it simple to include in your everyday routine
PT-141 - Libido Signaling & Melanocortin Activation Stimulates central desire pathways Activates melanocortin receptors Enhances reward-related signaling Acts centrally not peripherally Studied in female desire models Evaluated in male response studies Independent of nitric oxide signaling Studied for restoring diminished sexual desire and motivation Description PT-141 (Bremelanotide) is a synthetic melanocortin receptor agonist derived from alpha-MSH analog research
Its research interest lies in potency: published work reports activity at concentrations orders of magnitude below those required for brain-derived neurotrophic factor in comparable assays, which if replicated would place it among the most active synaptogenic compounds described
Semaglutide offers new route to cardiovascular risk reduction [PMID: 38036698] Laboratory literature summary: Semaglutide offers new route to cardiovascular risk reduction
US$ 19.99
US$ 26.12
US$ 22.57
US$ 28.91
US$ 27.47
US$ 24.57
